Published: Guidance, quality standards and advice
Showing 1011 to 1020 of 1113
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Hearing loss in adults | QS185 | ||
| Lyme disease | QS186 | ||
| Bisphosphonates for treating osteoporosis | TA464 | ||
| Long-acting reversible contraception | CG30 | ||
| Dementia | QS184 | ||
| The OPTIMIZER smart system for managing heart failure | MIB186 | ||
| Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality | TA322 | ||
| Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies | TA171 | ||
| Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib | TA586 | ||
| Lenalidomide plus dexamethasone for previously untreated multiple myeloma | TA587 |